Infection Control Find the newest stories covering infection and disease control in hospitals, care homes, and the general population. This section contains information on testing, monitoring, treatment options, vaccine development and distribution, as well as new policy decisions and best practices. Also included are announcements of educational and awareness campaigns. Follow new advances in infection control and prevention with releases about new study results and updated statistical data and analysis.

Latest

Nov 27, 2017, 21:33 ET United States Infectious Diagnostics Market Outlook to 2024

United States Infectious Diagnostics Market Outlook to 2024 Summary Read the full report: https://www.reportlinker.com/p03498788 GlobalData's...


Nov 27, 2017, 16:15 ET Centers for Disease Control and Prevention Award Leidos Prime Contract

Leidos (NYSE: LDOS), a FORTUNE 500 science and information technology company, was awarded a prime contract by the Centers for Disease Control and...


Nov 22, 2017, 16:17 ET Global Hepatitis Partnering 2010 to 2017

The Global Hepatitis Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered...


Nov 22, 2017, 15:53 ET Point-of-Care Infectious Disease Market 2021

This new 795-page report from VPGMarketResearch.com contains 61 tables, and provides a comprehensive analysis of the POC infectious disease...


Nov 22, 2017, 03:00 ET Lancement de « patients.debiopharm.com », un site internet sur les essais cliniques de Debiopharm International SA

Le site Internet fournit aux patients des renseignements utiles sur les essais cliniques de la société Debiopharm International SA...


Nov 22, 2017, 03:00 ET Debiopharm International SA Launches Clinical Trials Website: patients.debiopharm.com

Debiopharm International SA (Debiopharm - www.debiopharm.com), part of Debiopharm Group™, a Swiss-based global biopharmaceutical company,...


Nov 21, 2017, 18:06 ET Janssen Announces U.S. FDA Approval of First and Only Complete, Single-Pill, Two-Drug Regimen, JULUCA® (Dolutegravir and Rilpivirine), for the Treatment of HIV-1 Infection

Janssen Therapeutics, Division of Janssen Products, LP (Janssen), today announced that the U.S. Food and Drug Administration (FDA) has approved...


Nov 21, 2017, 15:00 ET Novus Therapeutics to Present at the 29th Annual Piper Jaffray Healthcare Conference

Novus Therapeutics, Inc. (NASDAQ: NVUS), a development stage specialty pharmaceutical company focused on the development of products for disorders...


Nov 21, 2017, 14:01 ET FDA approves first two-drug regimen for certain patients with HIV

The U.S. Food and Drug Administration today approved Juluca, the first complete treatment regimen containing only two drugs to treat certain adults...


Nov 21, 2017, 13:45 ET People in Four States May Be Drinking Contaminated Raw Milk

For the second time in three months, the Centers for Disease Control and Prevention is warning people who might have consumed contaminated raw milk...


Nov 21, 2017, 13:06 ET Unlimited, immediate access to publicly funded opioid agonist treatment with methadone could save California billions

Study finds if all opioid use disorder patients in 2014 had received immediate access to methadone, the total lifetime savings for that group would...


Nov 21, 2017, 13:00 ET New SLGE Report Finds That Shared Staffing Approaches Can Enhance Provision of Public Health Services

Public health challenges, such as disease outbreaks and substance abuse problems, do not recognize jurisdictional boundaries. "Staff Sharing...


Nov 21, 2017, 09:19 ET RESTANCE to Reveal Major Brand Name and Globally Recognized Logo to go on Condoms Manufactured in Campaign to End AIDS

RESTANCE, Inc. (USOTC: ANCE) today announced the company plans to reveal next week the major brand name and globally recognized logo that will...


Nov 20, 2017, 13:30 ET Amazon joins (RED) and the fight to end AIDS

(RED) and Amazon are teaming-up for (SHOPATHON)RED – a special holiday experience offering people a selection of exclusive (RED) products that...


Nov 20, 2017, 09:00 ET BiondVax and NIH Sign Clinical Trial Agreement for a Phase 2 Trial in the U.S. with BiondVax's Universal Flu Vaccine

BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV, TASE: BVXV) today announced the signing of the clinical trial agreement (CTA) for a Phase 2 clinical...


Nov 20, 2017, 08:30 ET RESTANCE Announces $500,000 Contract to Manufacture Brand Name Condoms for Distribution in Africa as Part of Campaign to end AIDS Epidemic

RESTANCE, Inc. (USOTC: ANCE) today announced a $500,000 contract to manufacture condoms under a major brand name for distribution in Africa. The...


Nov 16, 2017, 07:08 ET Meet the Experts: Mölnlycke 2017 Stop Pressure Ulcer Day Webinars

Mölnlycke, a world-leading medical solutions company, is presenting two expert webinars on pressure ulcer prevention. The free-of-charge broadcasts...


Nov 15, 2017, 08:30 ET Infectious Diseases Experts Train Clinicians to Research Effective Antibiotic Use

Today, healthcare professionals from across the U.S. are gathering to further national and hospital-based research to improve the use and...


Nov 14, 2017, 19:21 ET Kingdom of Saudi Arabia Amplifies Aid Distribution through Liberated Ports

The Yemeni Minister of Local Administration and the Higher Committee for Relief, His Excellency Abdulraqib Fatih, called on the United Nations and...


Nov 14, 2017, 13:18 ET airPHX Validates Technology for Eliminating Pathogens on Surfaces in Health Care Facilities

airPHX ("air fix") announces independent research confirming the effectiveness of airPHX technology in eliminating three common...